These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34598728)

  • 1. Medication errors associated with direct-acting oral anticoagulants: analysis of data from national pharmacovigilance and local incidents reporting databases.
    Alrowily A; Jalal Z; Abutaleb MH; Osman NA; Alammari M; Paudyal V
    J Pharm Policy Pract; 2021 Oct; 14(1):81. PubMed ID: 34598728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Views, experiences and contributory factors related to medication errors associated with direct oral anticoagulants: a qualitative study with physicians and nurses.
    Al Rowily A; Aloudah N; Jalal Z; Abutaleb MH; Paudyal V
    Int J Clin Pharm; 2022 Aug; 44(4):1057-1066. PubMed ID: 35731467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, contributory factors and severity of medication errors associated with direct-acting oral anticoagulants in adult patients: a systematic review and meta-analysis.
    Al Rowily A; Jalal Z; Price MJ; Abutaleb MH; Almodiaemgh H; Al Ammari M; Paudyal V
    Eur J Clin Pharmacol; 2022 Apr; 78(4):623-645. PubMed ID: 34935068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct oral anticoagulant-related medication incidents and pharmacists' interventions in hospital in-patients: evaluation using reason's accident causation theory.
    Haque H; Alrowily A; Jalal Z; Tailor B; Efue V; Sarwar A; Paudyal V
    Int J Clin Pharm; 2021 Dec; 43(6):1693-1704. PubMed ID: 34215959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributory factors and patient harm including deaths associated direct acting oral anticoagulants (DOACs) medication incidents: evaluation of real world data reported to the National Reporting and Learning System.
    Rowily AA; Jalal Z; Paudyal V
    Expert Opin Drug Saf; 2023; 22(11):1113-1125. PubMed ID: 37313587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mixed methodology, non-interventional study to evaluate the use of direct oral anticoagulants in UK clinical practice for patients with a first stroke associated with non-valvular atrial fibrillation: study protocol.
    Bhat Y; Dixit A; Mistri A; Patel B; Quoraishi SH; Uprichard J
    BMC Neurol; 2019 Nov; 19(1):306. PubMed ID: 31783738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in anticoagulant prescribing: a review of local policies in English primary care.
    Ho KH; van Hove M; Leng G
    BMC Health Serv Res; 2020 Apr; 20(1):279. PubMed ID: 32245380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose specific effectiveness and safety of DOACs in patients with non-valvular atrial fibrillation: A Canadian retrospective cohort study.
    Rahme E; Godin R; Nedjar H; Dasgupta K; Tagalakis V
    Thromb Res; 2021 Jul; 203():121-130. PubMed ID: 34000493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of major gastrointestinal tract surgery on the absorption and efficacy of direct acting oral anticoagulants (DOACs).
    Hakeam HA; Al-Sanea N
    J Thromb Thrombolysis; 2017 Apr; 43(3):343-351. PubMed ID: 28050755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid evidence assessment of bleed-related healthcare resource utilization in publications reporting the use of direct oral anticoagulants for non-valvular atrial fibrillation.
    Shah BR; Scholtus E; Rolland C; Batscheider A; Katz JN; Nilsson KR
    Curr Med Res Opin; 2019 Jan; 35(1):127-139. PubMed ID: 30380959
    [No Abstract]   [Full Text] [Related]  

  • 11. Real-World Adherence and Persistence to Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Ozaki AF; Choi AS; Le QT; Ko DT; Han JK; Park SS; Jackevicius CA
    Circ Cardiovasc Qual Outcomes; 2020 Mar; 13(3):e005969. PubMed ID: 32148102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and Safety of Anticoagulants in Adults with Non-valvular Atrial Fibrillation and Concomitant Coronary/Peripheral Artery Disease.
    Lopes RD; Steffel J; Di Fusco M; Keshishian A; Luo X; Li X; Masseria C; Hamilton M; Friend K; Gupta K; Mardekian J; Pan X; Baser O; Jones WS
    Am J Med; 2018 Sep; 131(9):1075-1085.e4. PubMed ID: 29807001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the efficacy of direct oral anticoagulants (DOACs) in comparison to warfarin in morbidly obese patients.
    Kalani C; Awudi E; Alexander T; Udeani G; Surani S
    Hosp Pract (1995); 2019 Oct; 47(4):181-185. PubMed ID: 31580732
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran or rivaroxaban compared with warfarin in the United States Medicare population.
    Amin A; Keshishian A; Trocio J; Dina O; Le H; Rosenblatt L; Liu X; Mardekian J; Zhang Q; Baser O; Vo L
    Curr Med Res Opin; 2017 Sep; 33(9):1595-1604. PubMed ID: 28635338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct oral anticoagulants in real clinical practice: analysis of patient characteristics and prescribing patterns in a large teaching hospital.
    Kováčová B; Červeňová J
    Pharmazie; 2017 Sep; 72(9):555-560. PubMed ID: 29441984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation.
    Jackevicius CA; Lu L; Ghaznavi Z; Warner AL
    Circ Cardiovasc Qual Outcomes; 2021 Feb; 14(2):e007230. PubMed ID: 33541109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Treatment With Apixaban, Dabigatran, Rivaroxaban, or Warfarin and Risk for Osteoporotic Fractures Among Patients With Atrial Fibrillation: A Population-Based Cohort Study.
    Lau WCY; Cheung CL; Man KKC; Chan EW; Sing CW; Lip GYH; Siu CW; Lam JKY; Lee ACH; Wong ICK
    Ann Intern Med; 2020 Jul; 173(1):1-9. PubMed ID: 32423351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication errors in relation to direct-acting oral anticoagulants: a qualitative study of pharmacists' views and experiences.
    Al Rowily A; Aloudah N; Jalal Z; Abutaleb M; Baraka M; Paudyal V
    Int J Clin Pharm; 2023 Jun; 45(3):681-688. PubMed ID: 36976394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Drug Switching and Discontinuation Rates in Patients with Nonvalvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States.
    Baker CL; Dhamane AD; Mardekian J; Dina O; Russ C; Rosenblatt L; Lingohr-Smith M; Menges B; Lin J; Nadkarni A
    Adv Ther; 2019 Jan; 36(1):162-174. PubMed ID: 30499067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication adherence to direct anticoagulants in patients with non-valvular atrial fibrillation - A real world analysis.
    Brízido C; Ferreira AM; Lopes P; Strong C; Sá Mendes G; Fernandes Gama F; Durazzo A; Rocha Rodrigues G; Matos D; Guerreiro S; Madeira S; Ferreira J; Adragão P; Mendes M
    Rev Port Cardiol (Engl Ed); 2021 Sep; 40(9):669-675. PubMed ID: 34503705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.